Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic Failure

NCT00735072 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
45
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of California, San Francisco

Collaborators